• Characterisation of the skin microbiota in patients with atopic dermatitis versus healthy controls See abstract > P. Philipp BOSSHARD (Zurich, Switzerland) • Crosstalk between intestinal microbiota, adipose tissue and skeletal muscle in obese exercising mice with experimental colitis supplemented with LPS-detoxifying intestinal alkaline phosphatase See abstract > D. Dagmara WÓJCIK (Kraków, Poland) • Identification of adipocytes as target cells for Leishmania infantum parasites See abstract > C. Christelle POMARES (Nice, France) • Proteomic analysis of Bartonella adhesin A and fibronectin gives insight into the molecular basis of bacterial adherence to human endothelial cells See abstract > D. Diana J. VACA (Frankfurt Am Main, Germany) • Effects of total and Th2-specific immunodeficiency on the intestinal murine microbiota in immunocompetent and immunodeficient mice See abstract > V. Vincent VAN AVERBEKE (Wilrijk, Belgium) • Development of a novel translational ex vivo model for investigation of host-pathogen interactions during acute pyelonephritis caused by uropathogenic Escherichia coli See abstract > P. Povilas KAVALIAUSKAS (New York, United States) • Apotransferrin in combination with induction chemotherapy protects against Escherichia coli infection in an acute myeloid leukaemia mouse model See abstract > D. Delfim DUARTE (Porto, Portugal) • Clostridium butyricum MIYAIRI 588 modifies lipid metabolism by the changing gut microbiota composition See abstract > T. Tadashi ARIYOSHI (Saitama, Japan) • Microbiota-associated risk factors for asymptomatic gut colonisation with multi-drug resistant organisms in a Dutch nursing home See abstract > Q. Quinten DUCARMON (Leiden, Netherlands) • Sarcoidosis related granuloma formation gene orthologs across lung microbiota See abstract > Y. Yordan HODZHEV (Sofia, Bulgaria)